Hepatitis B trials in Germany

4 of 6 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  Assessment of the safety and efficacy of a hepatitis B vaccine in adult patients with hepatitis B

  Where

  Berlin, Cologne, Frankfurt Am Main, Hamburg, Hanover, Leipzig, Munich, Wuerzburg

  Age

  18 years and over

  People

  69 worldwide

  Run by

  Klinikum der Universitaet Muenchen AöR

  See details and how to join2023-507623-36-00
• Phase 1Taking people
  An ascending dose study to determine the safety and effect of antibodies against hepatitis B (The SAMBA Study)

  Where

  Berlin

  Age

  18 years and over

  People

  48 worldwide

  Run by

  Region Midtjylland

  See details and how to join2023-508444-22-01
• Phase 1/2Taking people
  TherVacB - A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate

  Where

  Frankfurt, Hamburg, Hanover, Leipzig, Munich

  Age

  18 years to 70 years

  People

  81

  Run by

  Michael Hoelscher

  See details and how to joinNCT06513286
• Phase 1Taking people
  Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody: a Phase 1b, Open-label Trial in Individuals With Chronic Hepatitis D Infection

  Where

  Berlin

  Age

  18 years to 70 years

  People

  15 worldwide

  Run by

  Aarhus University Hospital

  See details and how to joinNCT07610772 · EU 2025-522125-36-00